ClinicalTrials.Veeva

Menu

Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section

U

Ufuk University

Status and phase

Completed
Phase 4

Conditions

Pain, Postoperative

Treatments

Drug: Levobupivacaine
Drug: Tramadol infusion via wound catheter

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients experience considerable amount of pain after cesarean section. The aim of this study is to investigate the effect of tramadol (an opioid pain killer) added to levobupivacaine (a local anesthetic) in continuous wound infusion (which is done by placing a catheter in the incision) after cesarean sections.

Enrollment

65 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Planned cesarean section
  • American Society of Anesthesiologists Class I-II

Exclusion criteria

  • Patients refusing to enroll in the study
  • Serious coagulopathy
  • Serious systemic disease
  • Story of allergy to drugs being used in the study
  • Morbid obesity (Body mass index > 30)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

65 participants in 3 patient groups, including a placebo group

Tramadol 1
Experimental group
Description:
1 mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion
Treatment:
Drug: Levobupivacaine
Drug: Tramadol infusion via wound catheter
Tramadol 2
Experimental group
Description:
2mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion
Treatment:
Drug: Levobupivacaine
Drug: Tramadol infusion via wound catheter
Levobupivacaine
Placebo Comparator group
Description:
0.25% levobupivacaine 4ml/h infusion
Treatment:
Drug: Levobupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems